FDA
-
-
-
-
-
-
-
Eledon reports Phase 2 kidney transplant drug data at ATC
-
-
-
-
-
-
-
Eledon reports 100% insulin independence in diabetes trial
-
-
-
-
-
-
-
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Eledon Pharmaceuticals (ELDN) Appoints Eliezer Katz as Chief Medical Officer
-
-
-
-
-
-
-
eGenesis and Eledon Pharmaceuticals Announce Collaboration for Use of Tegoprubart in Preclinical Xenotransplantation Studies
-
-
-
-
-
-
-
Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart in IgA Nephropathy
-
-
-
-
-
-
-
Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Pancreatic Islet Cell Transplantation
-
330,183 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

